Showing results (91-100 of 278) with videos related to
Sort By:
Pageof 28
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2017
Curative and palliative MRI-guided laser ablation for drug-resistant epilepsyMesha-Gay Brown, Cornelia Drees, Lidia M Nagae, et al.Transplantation|May 23, 2002
Glomerular targeting of acidic fibroblast growth factor-1 in renal transplanted ratsKurt R Zinn, Stacey Kelpke, Kabir Akhi, et al.Stereotactic and Functional Neurosurgery|November 23, 2020
Constant Current versus Constant Voltage: Clinical Evidence Supporting a Fundamental Difference in the ModalitiesDrew S Kern, Alfonso Fasano, John A Thompson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinomaJohn A Thompson, Robert A Figlin, Christi Sifri-Steele, et al.Journal of Cutaneous Pathology|July 29, 2018
Panniculitis in a patient with pathologic complete response to talimogene laherparepvec treatment for recurrent, in-transit melanomaThomas H Long, Michi M Shinohara, Zsolt B Argenyi, et al.Chemical Research in Toxicology|July 4, 2008
Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitroColin T Shearn, Kristofer S Fritz, Brent W Meier, et al.Chemico-Biological Interactions|February 28, 2003
Responses of tumorigenic and non-tumorigenic mouse lung epithelial cell lines to electrophilic metabolites of the tumor promoter butylated hydroxytolueneYude Sun, Lori D Dwyer-Nield, Alvin M Malkinson, et al.Pharmaceutical Research|November 10, 2011
Glucuronidation and methylation of procyanidin dimers b2 and 3,3″-di-o-galloyl-b2 and corresponding monomers epicatechin and 3-o-galloyl-epicatechin in mouse liverSuraj P Shrestha, John A Thompson, Michael F Wempe, et al.Best Practice & Research. Clinical Rheumatology|April 18, 2020
Immunologic adverse events from immune checkpoint therapyMichael D Richter, Grant C Hughes, Sarah H Chung, et al.Movement Disorders Clinical Practice|October 27, 2018
Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's DiseaseLaura J Weinkle, Brian Hoyt, John A Thompson, et al.Pageof 28